Earnings NewsHealthcareOn the MoveNGM Biopharmaceuticals EPS beats by $0.09, misses on revenueMar. 04, 2021 5:42 PM ETNGM Biopharmaceuticals, Inc. (NGM) StockNGMBy: SA News Team NGM Biopharmaceuticals (NASDAQ:NGM): Q4 GAAP EPS of -$0.40 beats by $0.09. Revenue of $19.77M (-36.4% Y/Y) misses by $1.76M. Shares +2% AH. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgNGM--NGM Biopharmaceuticals, Inc.Trending AnalysisTrending News